ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,664, issued on July 1, was assigned to MedImmune Ltd. (Cambridge, Great Britain).
"Antibodies to amyloid beta" was invented by Maria Groves (Cambridge, Great Britain), Suzanne Gustavsson (Huddinge, Sweden), Kina Hoglund (Solna, Sweden), Chris Lloyd (Cambridge, Great Britain), Adrian Nickson (Cambridge, Great Britain), Camilla Niva (Arsta, Sweden), Sylvia Simon (Stockholm), David Lowne (Cambridge, Great Britain), Fraser Welsh (Cambridge, Great Britain) and Per-Ola Freskgard (Sodertalje, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta...